Vertex Pharmaceuticals (NASDAQ:VRTX) and WuXi Biologics announced a major license and research service agreement on Monday, February 2, 2026, aimed at developing an innovative trispecific T-cell Engager (TCE) for B-cell mediated autoimmune diseases.
Leiden, Netherlands-based Pharming Group (NASDAQ:PHARM) provided 2026 financial guidance and detailed its rare disease pipeline at its Investor Day on February 3, 2026.
Boeing (NYSE:BA) and Air Cambodia announced the airline's first-ever purchase of Boeing aircraft on Tuesday, unveiling a deal for up to 20 737-8 jets at the 2026 Singapore Airshow.
The U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review to the supplemental Biologics License Application (sBLA) for DATROWAY® (datopotamab deruxtecan), a TROP2-directed antibody-drug conjugate (ADC).
In times of uncertainty, we often look for something solid to hold onto. Lately, it seems the world’s investors have decided that “something solid” is, quite literally, gold.
The metal’s soaring price is more than just a market trend; it's a global barometer of anxiety.
When faith in currencies, governments, and traditional financial systems begins to waver, we see a familiar flight to the perceived safety of this timeless asset.
Well, pull out the party hats and dust off the stock tickers.
Lithium, the commodity that investors and analysts had all but left for dead in the great market purge of 2023-2024, is back.
The stock market has long treated Tesla (NASDAQ:TSLA) less as a traditional automaker and more as a futuristic technology cult, with its valuation soaring on the gravitational pull of its CEO, Elon Musk.
This persistent "Musk Premium" has burned countless short-sellers.
Bitcoin has vaporised more than US$800 billion in its latest crash and sucked US$1 trillion out of the broader crypto market.
With nearly US$2 trillion in market value and rising allocations from Wall Street firms, ETFs, pension funds, and insurers, Bitcoin is increasingly woven into traditional finance.
Japan’s bond market has been sliding all week, with the 10-year yield now near 2.37% and the 40-year pushing above 4.2%, both multi-decade highs.
U.S. President Donald Trump has escalated his confrontation with European leaders on the eve of the World Economic Forum in Davos, threatening to impose a 200% tariff on French wine and champagne.
If you think the Formula 1 season finale in Abu Dhabi is just about who gets to spray the rose water, you aren’t looking at the balance sheet.
As the sun sets over the Yas Marina Circuit this weekend, we aren’t just witnessing a sporting event; we are watching the closing bell of one of the most efficient capital-generating machines in modern sports.
The Walt Disney Company (NYSE:DIS) reported a 5% increase in first-quarter revenue to $26 billion, a record high for the period, but saw its bottom line pressured by rising programming costs and a high-profile carriage dispute.
Tyson Foods (NYSE:TSN) reported a 5.1% increase in first-quarter revenue to $14.31 billion, surpassing Wall Street expectations as the meat giant’s diversified portfolio helped mitigate ongoing headwinds in its beef segment.
IDEXX Laboratories (NASDAQ:IDXX) reported fourth-quarter earnings that surpassed analyst expectations, fueled by double-digit growth in its core companion animal business and significant margin expansion.
Revvity (NYSE:RVTY) reported fourth-quarter and full-year 2025 results on Monday that exceeded Wall Street estimates, bolstered by resilient demand across its life sciences and diagnostics portfolios.
Ermenegildo Zegna (NYSE:ZGN) reported preliminary fiscal year 2025 revenues of €1.92 billion on Monday, as the Italian luxury group successfully leveraged its direct-to-consumer (DTC) strategy to offset a challenging wholesale environment and persistent volatility in China.
Hess Midstream (NYSE:HESM) reported fourth-quarter 2025 results on Monday that met analyst earnings expectations but fell slightly short on revenue, as severe winter weather in the Bakken region hampered throughput volumes.
Twist Bioscience (NASDAQ:TWST) reported first-quarter fiscal 2026 results Monday that beat revenue expectations and showed significant margin improvement, as the company stays on track to reach its profitability goals by the end of the year.
Dublin-based Aptiv (NYSE:APTV), a global technology company focused on enabling a more automated, electrified, and digitalized future, today reported record financial results for the fourth quarter and full year ended December 31, 2025.
-640x360.jpg&w=1200&q=75)
-640x360.jpg&w=1200&q=75)
-640x400.jpg&w=1200&q=75)
